Market Cap (In USD)
310.27 Thousand
Revenue (In USD)
-
Net Income (In USD)
-1.94 Million
Avg. Volume
5.79 Million
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.0E-4-0.0025
- PE
- -
- EPS
- -
- Beta Value
- 1.612
- ISIN
- US37960P1049
- CUSIP
- 37960P104
- CIK
- 1502152
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. James C. Katzaroff
- Employee Count
- -
- Website
- https://www.globestarthera.com
- Ipo Date
- 2011-09-26
- Details
- GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was incorporated in 2016 and is based in Richland, Washington.
More Stocks
-
NCLNorthann Corp.
NCL
-
PCARPACCAR Inc
PCAR
-
300380
-
TOE
-
IGLD-M
-
3648AGS Corporation
3648
-
BETRFBetterLife Pharma Inc.
BETRF
-
AUROPHARMAAurobindo Pharma Limited
AUROPHARMA